CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
Author:
Funder
Fundação de Amparo à Pesquisa do Estado de Goiás
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference22 articles.
1. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States;Kessler;Int. J. Methods Psychiatr. Res.,2012
2. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression;Ng;Hum. Psychopharmacol.,2013
3. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice;Trivedi;Am. J. Psychiatr.,2006
4. Drug metabolism and variability among patients in drug response;Wilkinson;N. Engl. J. Med.,2005
5. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response;Hodgson;J. Psychopharmacol.,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Influence of CYP2C19 Gene Polymorphism on Selective Serotonin Reuptake Inhibitors In Patients with Major Depressive Disorder: A Pharmacogenetic Prospecting Approach;Journal of Biomedicine and Translational Research;2024-04-29
2. Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype;Journal of Affective Disorders;2024-02
3. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study;Translational Psychiatry;2022-09-06
4. CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population;Frontiers in Pharmacology;2021-08-27
5. CYP2C19 polymorphisms are associated with severity of depression at initial evaluation and after the treatment independently of the prescribed medications: 4 weeks prospective study;Psychiatric Genetics;2021-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3